Standards; Chiral Molecules; Pharmaceutical/API Drug Impurities/Metabolites;
AR-C133913XX is an metabolte of Ticagrelor (T437700) which is the first reversible oral P2Y12 receptor antagonist, provides faster, greater, and more consistent ADP-receptor inhibition than Clopidogrel. Ticagrelor is used in the treatment of acute coronary syndromes (ACS).
400-821-0725
沪ICP备17019645号
